These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24867964)

  • 1. Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs.
    Diaz L; Tran TT; Munita JM; Miller WR; Rincon S; Carvajal LP; Wollam A; Reyes J; Panesso D; Rojas NL; Shamoo Y; Murray BE; Weinstock GM; Arias CA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4527-34. PubMed ID: 24867964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.
    Munita JM; Panesso D; Diaz L; Tran TT; Reyes J; Wanger A; Murray BE; Arias CA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4354-9. PubMed ID: 22664970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of liaR Reverses Daptomycin Resistance in Enterococcus faecium Independent of the Genetic Background.
    Panesso D; Reyes J; Gaston EP; Deal M; Londoño A; Nigo M; Munita JM; Miller WR; Shamoo Y; Tran TT; Arias CA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7327-34. PubMed ID: 26369959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome analysis of a daptomycin-susceptible enterococcus faecium strain and its daptomycin-resistant variant arising during therapy.
    Tran TT; Panesso D; Gao H; Roh JH; Munita JM; Reyes J; Diaz L; Lobos EA; Shamoo Y; Mishra NN; Bayer AS; Murray BE; Weinstock GM; Arias CA
    Antimicrob Agents Chemother; 2013 Jan; 57(1):261-8. PubMed ID: 23114757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LiaX is a surrogate marker for cell envelope stress and daptomycin non-susceptibility in
    Axell-House DB; Simar SR; Panesso D; Rincon S; Miller WR; Khan A; Pemberton OA; Valdez L; Nguyen AH; Hood KS; Rydell K; DeTranaltes AM; Jones MN; Atterstrom R; Reyes J; Sahasrabhojane PV; Suleyman G; Zervos M; Shelburne SA; Singh KV; Shamoo Y; Hanson BM; Tran TT; Arias CA
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0106923. PubMed ID: 38289081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Mutations Commonly Associated with Daptomycin Resistance in Enterococcus faecium LiaS
    Davlieva M; Wu C; Zhou Y; Arias CA; Shamoo Y
    Biochemistry; 2018 Dec; 57(49):6797-6805. PubMed ID: 30403130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Daptomycin Dose Exposure Alone or in Combination with β-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an
    Jahanbakhsh S; Singh NB; Yim J; Kebriaei R; Smith JR; Lev K; Tran TT; Rose WE; Arias CA; Rybak MJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094136
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of Inoculum Effect on the Efficacy of Daptomycin Monotherapy and in Combination with β-Lactams against Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions.
    Kebriaei R; Rice SA; Singh KV; Stamper KC; Dinh AQ; Rios R; Diaz L; Murray BE; Munita JM; Tran TT; Arias CA; Rybak MJ
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760141
    [No Abstract]   [Full Text] [Related]  

  • 9. A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis.
    Munita JM; Tran TT; Diaz L; Panesso D; Reyes J; Murray BE; Arias CA
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2831-3. PubMed ID: 23507277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium.
    Sakoulas G; Bayer AS; Pogliano J; Tsuji BT; Yang SJ; Mishra NN; Nizet V; Yeaman MR; Moise PA
    Antimicrob Agents Chemother; 2012 Feb; 56(2):838-44. PubMed ID: 22123698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
    Smith JR; Barber KE; Raut A; Rybak MJ
    Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Insights Into the Differential Efficacy of Daptomycin Plus β-Lactam Combinations Against Daptomycin-Resistant Enterococcus faecium.
    Kebriaei R; Stamper KC; Singh KV; Khan A; Rice SA; Dinh AQ; Tran TT; Murray BE; Arias CA; Rybak MJ
    J Infect Dis; 2020 Oct; 222(9):1531-1539. PubMed ID: 32514561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage-Antibiotic Cocktail Rescues Daptomycin and Phage Susceptibility against Daptomycin-Nonsusceptible Enterococcus faecium in a Simulated Endocardial Vegetation
    Kunz Coyne AJ; Stamper K; El Ghali A; Kebriaei R; Biswas B; Wilson M; Deschenes MV; Tran TT; Arias CA; Rybak MJ
    Microbiol Spectr; 2023 Aug; 11(4):e0034023. PubMed ID: 37338375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium.
    Humphries RM; Kelesidis T; Tewhey R; Rose WE; Schork N; Nizet V; Sakoulas G
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6051-3. PubMed ID: 22948885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Adaptive Mutation in Enterococcus faecium LiaR Associated with Antimicrobial Peptide Resistance Mimics Phosphorylation and Stabilizes LiaR in an Activated State.
    Davlieva M; Tovar-Yanez A; DeBruler K; Leonard PG; Zianni MR; Arias CA; Shamoo Y
    J Mol Biol; 2016 Nov; 428(22):4503-4519. PubMed ID: 27670715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing vancomycin-resistant Enterococcus strains with various mechanisms of daptomycin resistance developed in an in vitro pharmacokinetic/pharmacodynamic model.
    Steed ME; Vidaillac C; Rose WE; Winterfield P; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4748-54. PubMed ID: 21788457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Phosphodiesterase of the GdpP Family Modulates Cyclic di-AMP Levels in Response to Cell Membrane Stress in Daptomycin-Resistant Enterococci.
    Wang X; Davlieva M; Reyes J; Panesso D; Arias CA; Shamoo Y
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential steps of daptomycin resistance in Enterococcus faecium and reversion to hypersusceptibility through IS-mediated inactivation of the liaFSR operon.
    Sinel C; Cosquer T; Auzou M; Goux D; Giard JC; Cattoir V
    J Antimicrob Chemother; 2016 Oct; 71(10):2793-7. PubMed ID: 27353469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci.
    Hindler JA; Wong-Beringer A; Charlton CL; Miller SA; Kelesidis T; Carvalho M; Sakoulas G; Nonejuie P; Pogliano J; Nizet V; Humphries R
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4279-88. PubMed ID: 25963982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapy.
    Lellek H; Franke GC; Ruckert C; Wolters M; Wolschke C; Christner M; Büttner H; Alawi M; Kröger N; Rohde H
    Int J Med Microbiol; 2015 Dec; 305(8):902-9. PubMed ID: 26454536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.